Research finding suggested that Bax-deficiency alone promotes etoposide resistance in MEFs (McCurrach et al., 1997), while the overexpression of BAK confers sensitivity of drug-resistant upon MT1-Adr breast carcinoma (von Haefen et al., 2002). This evidence concerns the gene BAX and breast carcinoma.